CD40LG and cancer: Furthermore, analogous scFvFITC:sCD40L treatment schemes in which iDCs were co-cultured with a panel of various cancer cells types significant levels of IL-12 were induced, but only when these cancer types were pretargeted with a FITC-labelled antibody of appropriate specificity (Fig. 5H and Supplementary Table 1).